A Novel CYBB Mutation in Chronic Granulomatous Disease in Iran
-
Shaghayegh Tajik
,
Mohsen Badalzadeh
,
Mohammad Reza Fazlollahi
,
Massoud Houshmand
,
Fariborz Zandieh
,
Shamim Khandan
,
Zahra Pourpak
Abstract
Chronic granulomatous disease (CGD) is a rare primary immunodeficiency disorder due to a genetic defect in one of the components of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase complex. This complex is composed of membrane-bound gp91-phox and p22-phox subunits, and cytosolic subunits consisting of p47-phox, p67-phox, and p40-phox. A mutation in CYBB gene encoding gp91-phox located on chromosome Xp21.1, leads to X-linked CGD. Herein, we report a 4-year-old Iranian boy presented with episodes of recurrent fever, cervical lymphadenopathy, and abdominal abscesses. Mutation analysis of the CYBB gene in the patient indicated a one-nucleotide deletion, c.316delT, resulting in p.W106GfsX.
1. Segal BH, Leto TL, Gallin JI, Malech HL, Holland SM.Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine 2000; 79(3):170-200.
2. Winkelstein JA, Marino MC, Johnston Jr RB, Boyle J,Curnutte J, Gallin JI, et al. Chronic granulomatous disease: report on a national registry of 368 patients.Medicine 2000; 79(3):155-69.
3. Yu L, Zhen L, Dinauer MC. Biosynthesis of the phagocyte nadph oxidase cytochromeb 558 role of heme incorporation and heterodimer formation in maturation and stability of gp91 phox and p22 phox subunits. J Biol Chem 1997; 272(43):27288-94.
4. de Oliveira‐Junior E, Bustamante J, Newburger P, Condino‐Neto A. The human NADPH oxidase: primary and secondary defects impairing the respiratory burst function and the microbicidal ability of phagocytes. Scand J Immunol 2011; 73(5):420-7.
5. Holland SM. Chronic granulomatous disease. Clin Rev Allergy Immunol 2010; 38(1):3-10.
6. Roos D, De Boer M, Kuribayashi F, Meischl C, Weening R, Segal A, et al. Mutations in the X-linked and autosomal recessive forms of chronic granulomatous disease. Blood 1996; 87(5):1663-81.
7. Van Den Berg JM, Van Koppen E, Ahlin A, Belohradsky BH, Bernatowska E, Corbeel L, et al. Chronic granulomatous disease: the European experience. PloS one 2009; 4(4):e5234.
8. Fattahi F, Badalzadeh M, Sedighipour L, Movahedi M, Fazlollahi MR, Mansouri SD, et al. Inheritance pattern and clinical aspects of 93 Iranian patients with chronic granulomatous disease. J Clin Immunol 2011; 31(5):792-801.
9. Bakri FG, Martel C, Khuri-Bulos N, Mahafzah A, El- Khateeb MS, Al-Wahadneh AM, et al. First report of clinical, functional, and molecular investigation of chronic granulomatous disease in nine Jordanian families. J Clin Immunol 2009; 29(2):215-30.
10. Köker M, Sanal Ö, De Boer M, Tezcan I, Metin A, Ersoy F, et al. Mutations of chronic granulomatous disease in Turkish families. Eur J Clin Invest 2007; 37(7):589-95.
11. Wolach B, Gavrieli R, de Boer M, Gottesman G, Ben-Ari J, Rottem M, et al. Chronic granulomatous disease in Israel: clinical, functional and molecular studies of 38 patients. Expert Rev Clin Immunol 2008; 129(1):103-14.
12. Teimourian S, Rezvani Z, Badalzadeh M, Kannengiesser C, Mansouri D, Movahedi M, et al. Molecular diagnosis of X-linked chronic granulomatous disease in Iran. Int J Hematol 2008; 87(4):398-404.
| Files | ||
| Issue | Vol 15, No 5 (2016) | |
| Section | Case Report(s) | |
| Keywords | ||
| Chronic granulomatous disease (CGD) gp91-phox CYBB Iran Novel Mutation | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
